Stock Scorer

SeaStar Medical Holding Corp (ICU)

SeaStar Medical Holding Corp reported revenue of 615K USD for the quarter ending 30 June 2026, up 82.0% from 338K a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 615K +82.0%
Gross Profit Q2 '26 · ending 30 June 2026 561K +80.4%
Operating Income Q2 '26 · ending 30 June 2026 -3.8M —
Net Income Q2 '26 · ending 30 June 2026 -3.7M —
Cost of Revenue Q2 '26 · ending 30 June 2026 54K +100.0%
Operating Cash Flow Q2 '26 · ending 30 June 2026 -3M —
Shares Outstanding Q2 '26 · ending 30 June 2026 4.1M -52.6%
EPS Q2 '26 · ending 30 June 2026 -7.20 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 1.2M-12.2M-12.2M—
20242024-12-31 135K-17.8M-24.8M—
20232023-12-31 0-14.2M-26.2M—

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-30615K
Q1 '262026-03-31495K
Q4 '252025-12-31420K
Q3 '252025-09-30183K
Q2 '252025-06-30338K
Q1 '252025-03-31293K
Q4 '242024-12-3167K
Q3 '242024-09-3068K
Q2 '242024-06-300
Q1 '242024-03-310
Q4 '232023-12-310
Q3 '232023-09-300

Gross Profit Quarterly

PeriodEndingGross Profit
Q2 '262026-06-30561K
Q1 '262026-03-31449K
Q4 '252025-12-31408K
Q3 '252025-09-30169K
Q2 '252025-06-30311K
Q1 '252025-03-31293K
Q4 '242024-12-3167K
Q3 '242024-09-3068K
Q2 '242024-06-300
Q1 '242024-03-310

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-30-3.8M
Q1 '262026-03-31-3.6M
Q4 '252025-12-31-3M
Q3 '252025-09-30-3.6M
Q2 '252025-06-30-1.8M
Q1 '252025-03-31-3.8M
Q4 '242024-12-31-4.8M
Q3 '242024-09-30-4.5M
Q2 '242024-06-30-4.7M
Q1 '242024-03-31-4M
Q4 '232023-12-31-2.9M
Q3 '232023-09-30-2.9M
Q2 '232023-06-30-3.8M
Q1 '232023-03-31-4.6M
Q4 '222022-12-31-7.7M
Q3 '222022-09-30-1.8M
Q2 '222022-06-30-1.3M
Q1 '222022-03-31-812K
Q4 '212021-12-31-3.7M
Q3 '212021-09-30-411.4K

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30-3.7M
Q1 '262026-03-31-3.5M
Q4 '252025-12-31-2.9M
Q3 '252025-09-30-3.5M
Q2 '252025-06-30-2M
Q1 '252025-03-31-3.8M
Q4 '242024-12-31-4.4M
Q3 '242024-09-30-4.5M
Q2 '242024-06-30-3.2M
Q1 '242024-03-31-12.7M
Q4 '232023-12-31-9.5M
Q3 '232023-09-30-7.2M
Q2 '232023-06-30-2.4M
Q1 '232023-03-31-7.1M
Q4 '222022-12-31-8.4M
Q3 '222022-09-30-1.9M
Q2 '222022-06-30-902K
Q1 '222022-03-31-1M
Q4 '212021-12-31-4.6M
Q3 '212021-09-30236K

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262026-06-3054K
Q1 '262026-03-3146K
Q4 '252025-12-3112K
Q3 '252025-09-3014K
Q2 '252025-06-3027K
Q1 '252025-03-310
Q4 '242024-12-310
Q3 '242024-09-300
Q2 '242024-06-300
Q1 '242024-03-310
Q4 '232023-12-310
Q3 '232023-09-300

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30-3M
Q1 '262026-03-31-2.8M
Q4 '252025-12-31-4.1M
Q3 '252025-09-30-3.8M
Q2 '252025-06-30-3M
Q1 '252025-03-31-2.7M
Q4 '242024-12-31-4.7M
Q3 '242024-09-30-5M
Q2 '242024-06-30-2.8M
Q1 '242024-03-31-3.5M
Q4 '232023-12-31-4.5M
Q3 '232023-09-30-1.3M
Q2 '232023-06-30-2.2M
Q1 '232023-03-31-2.3M
Q4 '222022-12-31-5.3M
Q3 '222022-09-30-914K
Q2 '222022-06-30-991K
Q1 '222022-03-31-587K
Q4 '212021-12-31-4.7M
Q3 '212021-09-30-53.3K

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-304.1M
Q1 '262026-03-313.9M
Q3 '252025-09-3026.4M
Q2 '252025-06-3011.3M
Q1 '252025-03-318.6M
Q3 '242024-09-304.1M
Q2 '242024-06-303.2M
Q1 '242024-03-312.7M
Q3 '232023-09-30801.9K
Q2 '232023-06-30597.3K
Q1 '232023-03-3113M
Q3 '222022-09-307.2M
Q2 '222022-06-307.2M
Q1 '222022-03-317.2M
Q2 '212021-06-3013M
Q1 '212021-03-319.7M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-30-7.20
Q1 '262026-03-31-6.47
Q4 '252025-12-31-6.01
Q3 '252025-09-30-1.28
Q2 '252025-06-30-2.25
Q1 '252025-03-31-3.10
Q4 '242024-12-31-7.39
Q3 '242024-09-30-36.07
Q2 '242024-06-30-43.99
Q1 '242024-03-31-47.06
Q4 '232023-12-31-42.87
Q3 '232023-09-30-14.62
Q2 '232023-06-30-5.86
Q1 '232023-03-31-1.88
Q4 '222022-12-31-1.48